Proto Labs' stock fell sharply by 5.52% during intraday trading on Friday, marking a significant downturn for the manufacturing services provider.
The decline comes despite the company reporting strong first-quarter results that exceeded analyst expectations. Proto Labs posted Q1 revenue of $139.34 million, beating the IBES estimate of $135.1 million, while adjusted earnings per share reached $0.54, significantly higher than the $0.39 consensus estimate.
Market analysts suggest the sell-off may be attributed to the company's full-year 2026 revenue growth guidance of 6% to 8%, which some investors may view as conservative relative to expectations. Additionally, the stock had previously risen 13.7% during the quarter and gained 28.1% year-to-date, potentially leading to profit-taking following the earnings announcement.